MetaCap

Nuwellis (NUWE) vs Precision Optics (POCI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Precision Optics is the larger company by market cap ($45.3 million vs $1.8 million), about 24.6 times the size. Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -211.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NUWE+393.70%POCI-8.85%
+796%+351%-94%
Oct 7, 20261 yearNov 20, 2026
NUWE+394.92%POCI-10.04%
+763%+336%-92%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NUWE versus POCI key metrics
MetricNUWEPOCI
Share price$3.41$4.12
Market cap$1.84M$45.30M
1-day change-10.50%+1.41%
YTD return—-1.67%
1-year return—-10.43%
5-year return—-37.86%
P/E ratio (TTM)0.00—
Forward P/E—206.00
EPS (TTM)$3,609.63$-0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$8.27M$31.53M
Revenue growth (YoY)-5.38%+65.16%
Net income (latest FY)$-17.52M$-3.63M
Gross margin61.96%17.22%
Operating margin-134.29%-11.13%
Net margin-211.86%-11.51%
52-week high$1,556.10$6.15
52-week low$2.52$3.55
Distance from 52-week high-99.78%-33.01%
Analyst consensus—strong_buy
Avg. price target upside—+94.17%
Average volume829.19K43.00K
Shares outstanding540.91K10.99M
Employees38108
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Precision Optics is about 24.6 times larger than Nuwellis by market value ($45.30M vs $1.84M).
  • Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -211.9 cents for Nuwellis.
  • Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs -5.38%).

About Nuwellis

NUWE stock →

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees

About Precision Optics

POCI stock →

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees

NUWE vs POCI FAQ

Which is bigger, Nuwellis or Precision Optics?

Precision Optics (POCI) is larger, with a market capitalization of $45.30M compared with $1.84M for Nuwellis (NUWE).

Are Nuwellis and Precision Optics in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons